Reversible Regulation of the Transformed Phenotype of Ornithine Decarboxylase- and Ras-Overexpressing Cells by Dominant-Negative Mutants of c-Jun

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-3188-2PMID 15172983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

  2001influential reference
• Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes.

  2001cited by this paper
• Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice.

  2001cited by this paper
• Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.

  2000cited by this paper
• Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation

  2000cited by this paper
• Induced expression of dominant‐negative c‐jun downregulates NFκB and AP‐1 target genes and suppresses tumor phenotype in human keratinocytes

  2000cited by this paper
• C-Jun Activation-Dependent Tumorigenic Transformation Induced Paradoxically by Overexpression or Block of S-Adenosylmethionine Decarboxylase

  2000cited by this paper
• Signal transduction by the JNK group of MAP kinases.

  2000influential reference
• Cell cycle‐dependent variations in c‐Jun and JunB phosphorylation: a role in the control of cyclin D1 expression

  2000cited by this paper
• UC Irvine UC Irvine Previously Published Works Title Development of difluoromethylornithine ( DFMO ) as a chemoprevention agent

  2000cited by this paper
• Role of Mitogen-activated Protein Kinases and c-Jun/AP-1 trans-Activating Activity in the Regulation of Protease mRNAs and the Malignant Phenotype in NIH 3T3 Fibroblasts*

  1999cited by this paper
• Diverse functions of JNK signaling and c-Jun in stress response and apoptosis

  1999cited by this paper
• The expression of proto-oncogene c-jun in human pancreatic cancer.

  1999cited by this paper
• Control of cell cycle progression by c-Jun is p53 dependent.

  1999cited by this paper
• Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation

  1999cited by this paper
• c‐Jun regulates cell cycle progression and apoptosis by distinct mechanisms

  1999cited by this paper
• Polyamines

  1999cited by this paper
• The Jun Kinase 2 Isoform Is Preferentially Required for Epidermal Growth Factor-Induced Transformation of Human A549 Lung Carcinoma Cells

  1999cited by this paper
• Cell transformation by ornithine decarboxylase is associated with phosphorylation of the transactivation domain of c-Jun.

  1998influential reference
• Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.

  1998cited by this paper
• Ornithine decarboxylase induction in transformation by H-Ras and RhoA.

  1998cited by this paper
• A Guide to the Polyamines

  1998cited by this paper
• Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system.

  1997cited by this paper
• AP-1 function and regulation.

  1997cited by this paper
• Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression

  1997cited by this paper
• Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases

  1997cited by this paper
• Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors

  1997cited by this paper
• A cytoplasmic inhibitor of the JNK signal transduction pathway.

  1997influential reference
• Induction of apoptosis by the transcription factor c‐Jun

  1997cited by this paper
• Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.

  1997cited by this paper
• Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation.

  1996cited by this paper
• Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways

  1996cited by this paper
• Cellular transformation and malignancy induced by ras require c-jun

  1996cited by this paper
• Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus.

  1995cited by this paper
• Intramolecular signal transduction in c‐Jun.

  1995cited by this paper
• JUN cooperates with the ETS domain protein pointed to induce photoreceptor R7 fate in the Drosophila eye.

  1995cited by this paper
• Regulation of mammalian ornithine decarboxylase.

  1995cited by this paper
• Role of ornithine decarboxylase in epidermal tumorigenesis.

  1995cited by this paper
• Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1

  1994cited by this paper
• Polyomavirus middle-sized tumor antigen modulates c-Jun phosphorylation and transcriptional activity.

  1994cited by this paper
• Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cells

  1994cited by this paper
• MAPKs: new JNK expands the group.

  1994cited by this paper
• Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases.

  1994cited by this paper
• Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice.

  1994cited by this paper
• Mechanism of action of a dominant-negative mutant of c-Jun.

  1994cited by this paper
• JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

  1994cited by this paper
• Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.

  1994cited by this paper
• c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases

  1994cited by this paper
• The stress-activated protein kinase subfamily of c-Jun kinases

  1994cited by this paper
• Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.

  1993cited by this paper
• Polyamines are essential for cell transformation by pp60v-src: delineation of molecular events relevant for the transformed phenotype

  1993cited by this paper
• Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

  1993cited by this paper
• Suppression of oncogene-induced transformation by a deletion mutant of c-jun.

  1993cited by this paper
• Ornithine decarboxylase activity is critical for cell transformation

  1992cited by this paper
• Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73

  1992cited by this paper
• c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic.

  1992cited by this paper
• Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

  1991cited by this paper
• Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain

  1991cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991cited by this paper
• Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype.

  1990cited by this paper
• Molecular genetics of polyamine synthesis in eukaryotic cells.

  1990cited by this paper
• Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

  1990cited by this paper
• Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.

  1989cited by this paper
• The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells.

  1988cited by this paper
• Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy.

  1988cited by this paper
• Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts

  1988cited by this paper
• Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.

  1987cited by this paper
• Recent advances in the biochemistry of polyamines in eukaryotes.

  1986cited by this paper
• Polyamines.

  1984cited by this paper
• Suppression of a

  1969cited by this paper

• Silencing c-Jun inhibits autophagy and abrogates radioresistance in nasopharyngeal carcinoma by activating the PI3K/AKT/mTOR pathway

  2021cites this paper
• Prolyl 4‐hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls

  2020cites this paper
• Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells

  2018influential citation
• Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression

  2016cites this paper
• The ornithine decarboxylase, NO-synthase activitiesand phospho-c-Jun content under experimental gastric mucosa malignancy

  2016cites this paper
• Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.

  2014cites this paper
• Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.

  2012cites this paper
• TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.

  2012cites this paper
• The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun.

  2011cites this paper
• Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression

  2011cites this paper
• Chaotic neovascularization induced by aggressive fibrosarcoma cells overexpressing S-adenosylmethionine decarboxylase.

  2011cites this paper
• Identification of integrins α6 and β7 as c‐Jun‐ and transformation‐relevant genes in highly invasive fibrosarcoma cells

  2009cites this paper
• Blockade of AP‐1 activity by dominant‐negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1‐positive human nasopharyngeal carcinoma

  2007cites this paper
• Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target

  2007cites this paper
• Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.

  2007cites this paper
• Inhibition of the transcription factor AP-1 in cervical cancer

  2007cites this paper
• Thymosin B 4 Is a Determinant of the Transformed Phenotype and Invasiveness of S-Adenosylmethionine Decarboxylase – Transfected Fibroblasts

  2006cites this paper
• A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing.

  2006cites this paper
• Targeting transcription factors for cancer gene therapy.

  2006cites this paper
• Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism

  2006cites this paper
• Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence

  2006cites this paper
• Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage.

  2005cites this paper
• Decreased apoptosis and increased ornithine decarboxylase activity in the intestinal mucosa of rats with bilateral ventromedial hypothalamus lesions

  2005cites this paper
• Urokinase plasminogen activator receptor is upregulated by Helicobacter pylori in human gastric cancer AGS cells via ERK, JNK, and AP-1.

  2005cites this paper
• Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2.

  2005cites this paper
• Cited Articles Citing Articles E-mail Alerts

  year unknowncites this paper
• Osteopontin Promotes the Invasive Growth of Melanoma Cells by Activating Integrin alpha ( v ) beta ( 3 ) and Down-Regulating Tetraspanin CD 9

  year unknowncites this paper